PD/DLBの抗コリン薬と認知機能

書誌事項

タイトル別名
  • Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB

この論文をさがす

抄録

Overactive bladder (OAB) is a common autonomic disorder due mostly to lesions in the micturition-inhibiting area (D1 dopaminergic pathway in the basal ganglia) in Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). anticholinergic drugs are the mainstay in the treatment of OAB. However, since 1997, anticholinergic adverse events on the cognitive function have been recognized. Drugs with less lipophilic, less permeable through the blood-brain barrier are the choice in the treatment of OAB in elderly neurologic patients.

収録刊行物

  • 臨床神経学

    臨床神経学 53 (11), 1389-1392, 2013

    日本神経学会

参考文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ